The goals of the National Toxicology Program as they relate to immunological evaluation in toxicity assessment are discussed. The advantages of immune function assays for defining cellular injury as subtoxic levels following exposure to general or immunocyte specific chemical toxicants are proposed. A comprehensive screening panel of immune function and host resistance assays is presented in the context of an NIEHS approach for immunotoxicity assessment and methods selection. A second panel for defining the mechanism underlying immunological injury was also described. Studies utilizing these methods and approaches are described in companion papers by our group.
Introduction
A major objective of the National Toxicology Program (NTP) and a major effort at NIEHS is to examine a variety of in vivo and in vitro approaches to assess toxicity as well as newer research disciplines for evaluating chemicals of environmental concern. Immunology represents one of the disciplines that the NTP is employing to examine possible target organ toxicity as well as generalized toxicity at the cellular and molecular level. Furthermore, the effects of chemicals on host defense to bacterial, viral, fungal and parasitic diseases as well as the surveillance and destruction of neoplastically transformed cells are simultaneously being evaluated. It is our goal at NIEHS to apply systematically the disciplines of immunology and microbiology in a comprehensive manner to study immunotoxicity and altered host resis- Currently, a wide variety of assays is being utilized in the Immunology Program at the National Institute of Environmental Health Sciences to assess immunologic and host resistance alterations following chemical exposure (Table 1) . This is not to suggest that it is necessary or even desirable for evaluation laboratories to employ such a comprehensive assay panel. Rather, at our present stage of knowledge, it is reasonable that a few laboratories perform a comprehensive panel of assays concurrently to determine the relative simplicity, reproducibility and predictability of these methods for detecting altered immunological and host resistance functions. Some of these methods will undoubtably be selected to screen new chemicals and drugs for immunotoxicological potential. The detailed methodologies of these assays as performed at NIEHS have been described elsewhere in detail (3). These procedures were selected because they are reproducible and easily standardized. During the method selection phase of our research, major emphasis has been placed on assays that could be automated, routinized or require only microquantitates of cells or body fluids. These procedures involve the evaluation of pathotoxicology indicators, host resistance models, delayed-type hypersensitivity, cell-mediated immu- Table 1 (Table 2 ). These assays can provide additional information regarding mechanisms of immunotoxicity and may provide a means by which to circumvent or abolish the undesired effects of the agent. If the pathophysiologic mechanism responsible for the effect or the target cell is defined, possibly new analogs of the chemical or drug can be synthesized which produce the desirable effects but not the undesirable ones (e.g., synthetic penicillin).
The following papers in this session describe, in detail, methods and approaches utilized by leading laboratories in this rapidly developing field.
